Clinical Cardiology Alert – January 1, 2013
January 1, 2013
View Issues
-
PCI Outcomes in Women vs Men
Percutaneous coronary intervention (PCI) is performed in more than 600,000 patients annually in the United States, and women make up approximately one-third of this population. -
CABG Better in Elderly, PCI Better in Young?
As our population ages and outcomes from revascularization also improve, more elderly patients are being referred for coronary artery bypass graft surgery (CABG) and for percutaneous coronary intervention (PCI). -
Risk of Angioedema with Drug Therapy
Angioedema is an infrequent, but serious, adverse event from drug therapy. Drugs that affect the renin-angiotensin-aldosterone system have been linked to angioedema, but the relative frequency of this complication with these drugs is poorly understood. -
Risk of Bleeding with Warfarin Therapy for Atrial Fibrillation
This paper details the result of a population-based cohort study of all Ontario, Canada, residents older than 66 years of age who began warfarin therapy for atrial fibrillation over an 11-year period. -
Preventing Inappropriate ICD Shocks
This study, the Multicenter Automatic Defibrillator Implantation Trial Reduce Inappropriate Therapy (MADIT-RIT), was designed to test the hypothesis that programming implantable cardioverter-defibrillator (ICD) therapies with higher detection rates or delayed detection before initiation of therapy would decrease inappropriate shocks in ICD patients. -
Current Drug Usage in Atrial Fibrillation
This paper reviews drug therapy in patients with atrial fibrillation in the Medicare population. The author extracted a 5% sample of Medicare beneficiaries who were enrolled in Medicare Part D. -
Pharmacology Watch: Zolpidem and Risk of Falls in Hospitalized Patients
Zolpidem and risk of falls; AVR and anticoagulation; statins in cancer patients; and FDA actions. -
Clinical Briefs in Primary Care Supplement